Company news

Covalon Technologies Ltd. (TSXV:COV) news

Every Covalon Technologies Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Covalon Technologies Ltd. stock analysis →

Press releases & updates

Covalon Reports Fiscal 2026 Third Quarter Results

August 27, 2026

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results

August 20, 2026

Covalon Announces Appointment of New Director and DSU Grants

June 9, 2026

Covalon Reports 2026 Second Quarter Results

May 21, 2026

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results

May 14, 2026

Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

April 15, 2026

Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

April 10, 2026

Covalon Announces Grant of Deferred Share Units

March 27, 2026

Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders

March 26, 2026

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026

March 18, 2026

Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights

February 25, 2026

Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Co...

February 19, 2026

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

February 19, 2026

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

December 11, 2025

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

December 4, 2025

Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength

November 19, 2025

Covalon Declares First Ever Special Cash Dividend

October 21, 2025

Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025

October 20, 2025

Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet...

October 7, 2025

Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

September 25, 2025

Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair

September 23, 2025

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting

September 18, 2025

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting

September 18, 2025

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associ...

September 16, 2025

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-A...

September 16, 2025

Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance

August 21, 2025

Covalon Technologies Ltd. Achieves DTC Eligibility in the United States

August 20, 2025

CORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results

August 14, 2025

Covalon Reports Fifth Consecutive Quarter of Positive Earnings

May 28, 2025

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard

May 27, 2025

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard

May 27, 2025

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results

May 21, 2025

Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities

May 20, 2025

Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors

May 15, 2025

Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025

April 30, 2025

Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025

April 17, 2025

Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome

April 3, 2025

Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders

March 20, 2025

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025

March 12, 2025

Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings

February 21, 2025

Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company

February 19, 2025

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results

February 14, 2025

Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25...

September 24, 2024

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2...

September 19, 2024

Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Ac...

April 26, 2023

Covalon to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & Hold 1x1 Meetings on Thursday, April 27, 2023

April 20, 2023

Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination

March 27, 2023

Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, ...

March 20, 2023

Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders

March 9, 2023

Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors

March 9, 2023

Older →